Cytokinetics, Incorporated · NASDAQ:CYTK
Hessekiel Jeffrey sold 15,106 Cytokinetics, Incorporated shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 18, 2026
On Nov 17, 2026, Hessekiel Jeffrey (Chief Legal & Admin Officer) sold 15,106 Cytokinetics, Incorporated shares at US$52.62 for US$795K, leaving 92,837 shares. Filed Nov 18, 2026 (Form 4).
- Sold
- 15,106 shares
- Price
- US$52.62
- Value
- US$795K
- Holding after
- 92,837 shares
- Trading plan
- No
- Role
- Chief Legal & Admin Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Stock | Sale | 15,106 | US$52.62 | 92,837 | Direct |
Source
Download original · View original at SEC
Related
- Cytokinetics, Incorporated
- Hessekiel Jeffrey
- Cytokinetics, Incorporated shareholders
- Form 4 · Malik Fady Ibraham · Nov 18, 2026
- Form 4 · Blum Robert I · Nov 18, 2026
- Schedule 13G/A · Wellington Management Group LLP · Nov 16, 2026
- Form 4 · Parshall B Lynne · Nov 12, 2026
- Schedule 13G · State Street Corp · Nov 10, 2026